The docs are doing it again at New York Methodist Hospital. Cutting-edge oncologists are offering a new treatment in the fight against advanced stages of metastatic prostate cancer. The therapy, called radium-223 dichloride, is administered once a month for six months on an outpatient basis with a simple injection. It specifically targets and kills cancer cells that have spread to a patient’s bones while minimizing harm to healthy tissue. Of course, the healing center is the only hospital in Brooklyn to offer the treatment.
“When prostate cancer metastasizes (spreads), it is most commonly to the bones,” said Dr. Hani Ashamalla, chairman of radiation oncology. “Now, thanks to radium-223 therapy, patients at this stage of the disease have not run out of effective options.”
Chief of Urology Dr. Ivan Grunberger added, “Combined with other treatments for metastatic prostate cancer that are available here, radium-223 therapy packs an additional punch that can help our patients live longer, and live better, too.”
Standing O says, “Keep up the fight.”
New York Methodist Hospital [506 Sixth St. between Seventh and Eighth avenues in Park Slope, (718) 780–3000].
Yes, you’re in the right place — Brooklyn Paper is the new online home of BrooklynDaily.com.
So bookmark this page, and remember check it throughout the day for the latest stories from your neighborhood — and across this great borough of ours.